Hansen KB, Yi F, Perszyk RE, et al. Structure, function, and allosteric modulation of NMDA receptors. J Gen Physiol. 2018;150:1081–105.
Article CAS PubMed PubMed Central Google Scholar
Li XH, Miao HH, Zhuo M. NMDA receptor dependent long-term potentiation in chronic pain. Neurochem Res. 2018;3:531–8.
Theibert HPM, Carroll BT. NMDA antagonists in the treatment of catatonia: a review of case studies from the last 10 years. Gen Hosp Psychiatry. 2018;51:132–3.
Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci. 2007;8:413–26.
Article CAS PubMed Google Scholar
Zorumski CF, Izumi Y. NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders. Neurosci Biobehav Rev. 2012;36:989–1000.
Article CAS PubMed PubMed Central Google Scholar
Monaco SA, Gulchina Y, Gao WJ. NR2B subunit in the prefrontal cortex: a double-edged sword for working memory function and psychiatric disorders. Neurosci Biobehav Rev. 2015;56:127–38.
Article CAS PubMed PubMed Central Google Scholar
Weissman AD, Su TP, Hedreen JC, London ED. Sigma receptors in post-mortem human brains. J Pharmacol Exp Ther. 1988;247:29–33.
Chu UB, Ruoho AE. Biochemical pharmacology of the sigma-1 receptor. Mol Pharmacol. 2016;89:142–53.
Article CAS PubMed Google Scholar
Pabba M, Wong AY, Ahlskog N, et al. NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus. J Neurosci. 2014;34:11325–38.
Article PubMed PubMed Central Google Scholar
Maurice T, Su TP. The pharmacology of sigma-1 receptors. Pharmacol Ther. 2009;124:195–206.
Article CAS PubMed PubMed Central Google Scholar
Rousseaux CG, Greene SF. Sigma receptors [sigmaRs]: biology in normal and diseased states. J Recept Signal Transduct Res. 2016;36:327–88.
Lupardus PJ, Wilke RA, Aydar E, et al. Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol. 2000;526(Pt 3):527–39.
Article CAS PubMed PubMed Central Google Scholar
Aydar E, Palmer CP, Klyachko VA, Jackson MB. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron. 2002;34:399–410.
Article CAS PubMed Google Scholar
Tchedre KT, Huang RQ, Dibas A, Krishnamoorthy RR, Dillon GH, Yorio T. Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. Invest Ophthalmol Vis Sci. 2008;49:4993–5002.
Zhang H, Katnik C, Cuevas J. Sigma receptor activation inhibits voltage-gated sodium channels in rat intracardiac ganglion neurons. Int J Physiol Pathophysiol Pharmacol. 2009;2:1–11.
PubMed PubMed Central Google Scholar
Kinoshita M, Matsuoka Y, Suzuki T, Mirrielees J, Yang J. Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands. Brain Res. 2012;1452:1–9.
Article CAS PubMed PubMed Central Google Scholar
Martina M, Turcotte ME, Halman S, Bergeron R. The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol. 2007;578:143–57.
Article CAS PubMed Google Scholar
Zhang XJ, Liu LL, Jiang SX, Zhong YM, Yang XL. Activation of the zeta receptor 1 suppresses NMDA responses in rat retinal ganglion cells. Neuroscience. 2011;177:12–22.
Article CAS PubMed Google Scholar
Zhang XJ, Liu LL, Wu Y, Jiang SX, Zhong YM, Yang XL. sigma receptor 1 is preferentially involved in modulation of N-methyl-D-aspartate receptor-mediated light-evoked excitatory postsynaptic currents in rat retinal ganglion cells. Neurosignals. 2011;19:110–6.
Article CAS PubMed Google Scholar
Pabba M, Sibille E. Sigma-1 and N-methyl-d-aspartate receptors: a partnership with beneficial outcomes. Mol Neuropsychiatry. 2015;1:47–51.
PubMed PubMed Central Google Scholar
Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R. Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat. 2000;20:375–87.
Article CAS PubMed Google Scholar
Avenet P, Leonardon J, Besnard F, et al. Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Eur J Pharmacol. 1996;296:209–13.
Article CAS PubMed Google Scholar
Lengyel C, Dezsi L, Biliczki P, et al. Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk. Br J Pharmacol. 2004;143:152–8.
Article CAS PubMed PubMed Central Google Scholar
Haider A, Herde AM, Kramer SD, et al. Preclinical evaluation of benzazepine-based PET radioligands (R)- and (S)-(11)C-Me-NB1 reveals distinct enantiomeric binding patterns and a tightrope walk between GluN2B- and sigma1-receptor-targeted PET imaging. J Nucl Med. 2019;60:1167–73.
Article CAS PubMed PubMed Central Google Scholar
Haider A, Iten I, Ahmed H, et al. Identification and preclinical evaluation of a radiofluorinated benzazepine derivative for imaging the GluN2B subunit of the ionotropic NMDA receptor. J Nucl Med. 2019;60:259–66.
Article CAS PubMed Central Google Scholar
Cai L, Liow JS, Morse CL, et al. Evaluation of (11)C-NR2B-SMe and its enantiomers as PET radioligands for imaging the NR2B subunit within the NMDA receptor complex in rats. J Nucl Med. 2020;61:00–000.
James ML, Shen B, Zavaleta CL, et al. New positron emission tomography (PET) radioligand for imaging sigma-1 receptors in living subjects. J Med Chem. 2012;55:8272–82.
Article CAS PubMed PubMed Central Google Scholar
Pike VW. Considerations in the development of reversibly binding PET radioligands for brain imaging. Curr Med Chem. 2016;23:1818–69.
Article CAS PubMed PubMed Central Google Scholar
Mutel V, Buchy D, Klingelschmidt A, et al. In vitro binding properties in rat brain of [3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J Neurochem. 1998;70:2147–55.
Article CAS PubMed Google Scholar
Patel S, Gibson R. In vivo site-directed radiotracers: a mini-review. Nucl Med Biol. 2008;35:805–15.
Article CAS PubMed Google Scholar
Ahmed H, Haider A, Varisco J, et al. Structure-affinity relationships of 2,3,4,5-tetrahydro-1H-3-benzazepine and 6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-amine analogues and the discovery of a radiofluorinated 2,3,4,5-tetrahydro-1H-3-benzazepine congener for imaging GluN2B subunit-containing N-methyl-d-aspartate receptors. J Med Chem. 2019;62:9450–70.
Article CAS PubMed Google Scholar
Jin DH, Jung YW, Ko BH, Moon IS. Immunoblot analyses on the differential distribution of NR2A and NR2B subunits in the adult rat brain. Mol Cells. 1997;7:749–54.
Wang YH, Bosy TZ, Yasuda RP, et al. Characterization of NMDA receptor subunit-specific antibodies: distribution of NR2A and NR2B receptor subunits in rat brain and ontogenic profile in the cerebellum. J Neurochem. 1995;65:176–83.
Article CAS PubMed Google Scholar
Chen G, Li Q, Feng D, Hu T, Fang Q, Wang Z. Expression of NR2B in different brain regions and effect of NR2B antagonism on learning deficits after experimental subarachnoid hemorrhage. Neuroscience. 2013;231:136–44.
Article CAS PubMed Google Scholar
Akazawa C, Shigemoto R, Bessho Y, Nakanishi S, Mizuno N. Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J Comp Neurol. 1994;347:150–60.
Article CAS PubMed Google Scholar
Fischer G, Mutel V, Trube G, et al. Ro 25–6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. J Pharmacol Exp Ther. 1997;283:1285–92.
Zhou ZL, Cai SX, Whittemore ER, et al. 4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist. J Med Chem. 1999;42:2
留言 (0)